Alain Roccon

527 total citations
21 papers, 454 citations indexed

About

Alain Roccon is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Alain Roccon has authored 21 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pharmacology. Recurrent topics in Alain Roccon's work include Receptor Mechanisms and Signaling (8 papers), Renin-Angiotensin System Studies (5 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Alain Roccon is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Renin-Angiotensin System Studies (5 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Alain Roccon collaborates with scholars based in France, United States and Mexico. Alain Roccon's co-authors include Catherine Cazaubon, Dino Nisato, C Lacour, Jean Gougat, P. Guiraudou, G Galindo, Gérard Barthélémy, Bruno Gautret, Patrick Gautier and B. Ferrari and has published in prestigious journals such as Blood, PLoS ONE and Analytical Chemistry.

In The Last Decade

Alain Roccon

20 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Roccon France 10 254 169 96 82 47 21 454
Jean Gougat France 5 163 0.6× 136 0.8× 70 0.7× 76 0.9× 52 1.1× 10 380
M. Dubar France 10 318 1.3× 75 0.4× 126 1.3× 44 0.5× 44 0.9× 16 536
Kiyoshi Oizumi Japan 16 183 0.7× 228 1.3× 63 0.7× 141 1.7× 32 0.7× 28 588
Mami Ojima Japan 8 272 1.1× 152 0.9× 171 1.8× 99 1.2× 34 0.7× 10 471
Hideki Igata Japan 8 235 0.9× 196 1.2× 90 0.9× 112 1.4× 24 0.5× 15 511
Taketoshi Ogawa Japan 14 541 2.1× 98 0.6× 82 0.9× 146 1.8× 35 0.7× 30 827
Michael E. Beil Switzerland 12 144 0.6× 125 0.7× 149 1.6× 32 0.4× 36 0.8× 28 447
Thomas L. Waldron United States 12 190 0.7× 177 1.0× 91 0.9× 117 1.4× 46 1.0× 25 473
Tsukasa Sanada Japan 9 345 1.4× 215 1.3× 197 2.1× 35 0.4× 46 1.0× 13 491
P C Wong United States 8 343 1.4× 294 1.7× 181 1.9× 86 1.0× 73 1.6× 10 579

Countries citing papers authored by Alain Roccon

Since Specialization
Citations

This map shows the geographic impact of Alain Roccon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Roccon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Roccon more than expected).

Fields of papers citing papers by Alain Roccon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Roccon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Roccon. The network helps show where Alain Roccon may publish in the future.

Co-authorship network of co-authors of Alain Roccon

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Roccon. A scholar is included among the top collaborators of Alain Roccon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Roccon. Alain Roccon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poirier, Bruno, Anne‐Marie Lefebvre, Alain Roccon, et al.. (2022). A G-protein-biased S1P1 agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome. PLoS ONE. 17(1). e0257929–e0257929. 6 indexed citations
2.
3.
4.
Roccon, Alain, Shujia Dai, Valérie Boutet, et al.. (2019). M-Protein semi-quantification in MM serum patients based on Immuno-Capture and Liquid Chromatography coupled to High Resolution Mass Spectrometry. Clinical Lymphoma Myeloma & Leukemia. 19(10). e149–e150. 2 indexed citations
5.
Gautier, Patrick, et al.. (2011). Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 384(3). 231–244. 4 indexed citations
6.
Gautier, Patrick, et al.. (2005). In Vivo and In Vitro Antiarrhythmic Effects of SSR149744C in Animal Models of Atrial Fibrillation and Ventricular Arrhythmias. Journal of Cardiovascular Pharmacology. 45(2). 125–135. 29 indexed citations
7.
Lacour, C, Alain Roccon, G Galindo, et al.. (2004). Effects of differential blockade of the renin‐angiotensin system in postinfarcted rats. Fundamental and Clinical Pharmacology. 18(3). 299–307. 3 indexed citations
8.
Pucheu, Sylvie, et al.. (2004). Involvement of nitric oxide in amiodarone- and dronedarone-induced coronary vasodilation in guinea pig heart. European Journal of Pharmacology. 496(1-3). 119–127. 30 indexed citations
9.
Roccon, Alain, G Rizzoli, P. Guiraudou, et al.. (2003). 301 SSR149744, a new antiarrhythmic drug, prevents experimental induced atrial fibrillation. European Journal of Heart Failure Supplements. 2(1). 53–54. 2 indexed citations
10.
Lacour, C, G Galindo, Catherine Cazaubon, et al.. (2000). Aquaretic and hormonal effects of a vasopressin V2 receptor antagonist after acute and long-term treatment in rats. European Journal of Pharmacology. 394(1). 131–138. 12 indexed citations
11.
Roccon, Alain, et al.. (1996). Study of SR 142801, a new potent non‐peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea‐pig. British Journal of Pharmacology. 118(5). 1095–1102. 27 indexed citations
12.
Roccon, Alain, et al.. (1994). A pharmacodynamic study of SR 47436, a selective AT1 receptor antagonist, on blood pressure in conscious cynomolgus monkeys. British Journal of Pharmacology. 111(1). 145–150. 15 indexed citations
13.
Gougat, Jean, C Lacour, Alain Roccon, et al.. (1994). Cyclopentanespiro-3H-dihydro-pyrimidinones as Angiotensin II AT1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 157–162. 5 indexed citations
14.
Ferrari, Bernard, Jacques Clément, Jean Gougat, et al.. (1994). ChemInform Abstract: A New Series of Imidazolones: Highly Specific and Potent Nonpeptide AT1 Angiotensin II Receptor Antagonists.. ChemInform. 25(11).
15.
Ferrari, B., Jean Gougat, P. Guiraudou, et al.. (1994). Development of tetrazole bioisosteres in angiotensin II antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 45–50. 11 indexed citations
16.
Ferrari, B., Jacques Clément, Jean Gougat, et al.. (1993). A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists. Journal of Medicinal Chemistry. 36(22). 3371–3380. 86 indexed citations
17.
Cazaubon, Catherine, Jean Gougat, P. Guiraudou, et al.. (1993). Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 826–834. 174 indexed citations
18.
Lacour, C, et al.. (1993). Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys.. PubMed. 11(11). 1187–94. 12 indexed citations
19.
Lacour, C, et al.. (1991). A pharmacodynamic study of the rennin inhibitor SR 43 845, administered intratracheally in conscious cynomolgus monkeys. Journal of Hypertension. 9(6). S386–S386. 2 indexed citations
20.
Lacour, C, et al.. (1989). Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca. Journal of Hypertension. 7(2). S33–S36. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Gougat Breakdown of academic impact, for papers by M. Dubar Breakdown of academic impact, for papers by Kiyoshi Oizumi Breakdown of academic impact, for papers by Mami Ojima Breakdown of academic impact, for papers by Hideki Igata Breakdown of academic impact, for papers by Taketoshi Ogawa Breakdown of academic impact, for papers by Michael E. Beil Breakdown of academic impact, for papers by Thomas L. Waldron Breakdown of academic impact, for papers by Tsukasa Sanada Breakdown of academic impact, for papers by P C Wong
Rankless by CCL
2026